Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder

REFERENCES

1. 1.↵
   1. Meijer JM,
   2. Meiners PM,
   3. Vissink A,
   4. Spijkervet FK,
   5. Abdulahad W,
   6. Kamminga N,
   7. et al.

   Effectiveness of rituximab treatment in primary Sjogren’s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010;62:960–8.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Longoni G,
   2. Banwell B,
   3. Filippi M,
   4. Yeh EA

   . Rituximab as a first-line preventive treatment in pediatric NMOSDs: preliminary results in 5 children. Neurol Neuroimmunol Neuroinflamm 2014;1:e46.

   OpenUrlCrossRef
3. 3.↵
   1. Banwell B,
   2. Tenembaum S,
   3. Lennon VA,
   4. Ursell E,
   5. Kennedy J,
   6. Bar-Or A,
   7. et al.

   Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008;70:344–52.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. McKeon A,
   2. Lennon VA,
   3. Lotze T,
   4. Tenenbaum S,
   5. Ness JM,
   6. Rensel M,
   7. et al.

   CNS aquaporin-4 autoimmunity in children. Neurology 2008;71:93–100.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Wingerchuk DM,
   2. Banwell B,
   3. Bennett JL,
   4. Cabre P,
   5. Carroll W,
   6. Chitnis T,
   7. et al;
   8. International Panel for NMO Diagnosis

   . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–89.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Cimaz R,
   2. Casadei A,
   3. Rose C,
   4. Bartunkova J,
   5. Sediva A,
   6. Falcini F,
   7. et al.

   Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 2003;162:661–5.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Movva S,
   2. Carsons S

   . Review of pediatric Sjogren’s syndrome. Pediatr Allergy Immunol Pulmonol 2014;27:111–1146.

   OpenUrlCrossRef
8. 8.↵
   1. Arabshahi B,
   2. Pollock AN,
   3. Sherry DD,
   4. Albert DA,
   5. Kreiger PA,
   6. Pessler F

   . Devic disease in a child with primary Sjogren syndrome. J Child Neurol 2006;21:285–6.

   OpenUrlFREE Full Text
9. 9.↵
   1. Carvalho DC,
   2. Tironi TS,
   3. Freitas DS,
   4. Kleinpaul R,
   5. Talim NC,
   6. Lana-Peixoto MA

   . Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu. Arq Neuropsiquiatr 2014;72:619–24.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Lotze TE,
    2. Northrop JL,
    3. Hutton GJ,
    4. Ross B,
    5. Schiffman JS,
    6. Hunter JV

    . Spectrum of pediatric neuromyelitis optica. Pediatrics 2008;122:e1039–47.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Yokogawa N,
    2. Lieberman SM,
    3. Alawi F,
    4. Bout-Tabaku S,
    5. Guttenberg M,
    6. Sherry DD,
    7. et al.

    Comparison of labial minor salivary gland biopsies from childhood Sjogren syndrome and age-matched controls. J Rheumatol 2014;41:1178–82.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Graber DJ,
    2. Levy M,
    3. Kerr D,
    4. Wade WF

    . Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 2008;5:22.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Gresz V,
    2. Kwon TH,
    3. Hurley PT,
    4. Varga G,
    5. Zelles T,
    6. Nielsen S,
    7. et al.

    Identification and localization of aquaporin water channels in human salivary glands. Am J Physiol Gastrointest Liver Physiol 2001;281:G247–54.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Mobasheri A,
    2. Marples D,
    3. Young IS,
    4. Floyd RV,
    5. Moskaluk CA,
    6. Frigeri A

    . Distribution of the AQP4 water channel in normal human tissues: protein and tissue microarrays reveal expression in several new anatomical locations, including the prostate gland and seminal vesicles. Channels 2007;1:29–38.

    OpenUrlPubMed
15. 15.↵
    1. Wingerchuk DM,
    2. Weinshenker BG

    . The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012;18:5–10.

    OpenUrlAbstract/FREE Full Text